Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Fischer

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Progress in Cell Cycle Research|November 5, 2003
Cyclin-dependent kinase inhibitorsPeter M Fischer, Jane Endicott, Laurent Meijer
Current Topics in Medicinal Chemistry|April 28, 2005
Progress in the discovery of polo-like kinase inhibitorsCampbell McInnes, Mokdad Mezna, Peter M Fischer
Journal of Medicinal Chemistry|January 6, 2006
Protein structures in virtual screening: a case study with CDK2Mark P Thomas, Campbell McInnes, Peter M Fischer
Seminars in Cancer Biology|November 10, 2009
Small-molecule inhibitors of MDM2 as new anticancer therapeuticsMichael P Dickens, Ross Fitzgerald, Peter M Fischer
The Journal of Organic Chemistry|September 25, 2004
Efficient palladium-catalyzed cross-coupling of beta-chloroalkylidene/arylidene malonates using microwave chemistryRajamohan R Poondra, Peter M Fischer, Nicholas J Turner
Mini Reviews in Medicinal Chemistry|April 18, 2003
The p53-Mdm2 pathway: targets for the development of new anticancer therapeuticsDaniella I Zheleva, David P Lane, Peter M Fischer
Molecules (Basel, Switzerland)|July 2, 2014
Investigation of the flexibility of protein kinases implicated in the pathology of Alzheimer's diseaseMichael P Mazanetz, Charles A Laughton, Peter M Fischer
Bioorganic & Medicinal Chemistry Letters|March 4, 2006
Synthesis and biological activity of conjugates between paclitaxel and the cell delivery vector penetratinShudong Wang, Nikolai Z Zhelev, Susan Duff, et al.
Biomolecules|November 27, 2025
Discovery of Drug-like Inhibitors of the Human Caf1/CNOT7 poly(A)-Selective Nuclease Using Compound ScreeningIshwinder Kaur, Lubna Hashmi, Peter M Fischer, et al.
Investigational New Drugs|February 19, 2011
In vitro antitumor mechanism of a novel cyclin-dependent kinase inhibitor CDKI-83Xiangrui Liu, Frankie Lam, Shenhua Shi, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Progress in Cell Cycle Research|November 5, 2003
Cyclin-dependent kinase inhibitorsPeter M Fischer, Jane Endicott, Laurent Meijer
Current Topics in Medicinal Chemistry|April 28, 2005
Progress in the discovery of polo-like kinase inhibitorsCampbell McInnes, Mokdad Mezna, Peter M Fischer
Journal of Medicinal Chemistry|January 6, 2006
Protein structures in virtual screening: a case study with CDK2Mark P Thomas, Campbell McInnes, Peter M Fischer
Seminars in Cancer Biology|November 10, 2009
Small-molecule inhibitors of MDM2 as new anticancer therapeuticsMichael P Dickens, Ross Fitzgerald, Peter M Fischer
The Journal of Organic Chemistry|September 25, 2004
Efficient palladium-catalyzed cross-coupling of beta-chloroalkylidene/arylidene malonates using microwave chemistryRajamohan R Poondra, Peter M Fischer, Nicholas J Turner
Mini Reviews in Medicinal Chemistry|April 18, 2003
The p53-Mdm2 pathway: targets for the development of new anticancer therapeuticsDaniella I Zheleva, David P Lane, Peter M Fischer
Molecules (Basel, Switzerland)|July 2, 2014
Investigation of the flexibility of protein kinases implicated in the pathology of Alzheimer's diseaseMichael P Mazanetz, Charles A Laughton, Peter M Fischer
Bioorganic & Medicinal Chemistry Letters|March 4, 2006
Synthesis and biological activity of conjugates between paclitaxel and the cell delivery vector penetratinShudong Wang, Nikolai Z Zhelev, Susan Duff, et al.
Biomolecules|November 27, 2025
Discovery of Drug-like Inhibitors of the Human Caf1/CNOT7 poly(A)-Selective Nuclease Using Compound ScreeningIshwinder Kaur, Lubna Hashmi, Peter M Fischer, et al.
Investigational New Drugs|February 19, 2011
In vitro antitumor mechanism of a novel cyclin-dependent kinase inhibitor CDKI-83Xiangrui Liu, Frankie Lam, Shenhua Shi, et al.
Pageof 12